Green Synthesis of Quinoline-Based Ionic Liquid
September 27th, 2024
In the present work, we elucidate the green synthesis of quinoline-based Ionic Liquid (IL), namely, 1-Hexadecylquinolin-1-ium bromide {[C16quin]Br} by mixing quinoline with an excess of 1-Bromohexadecane, along with its detailed characterization using Nuclear Magnetic Resonance and Infrared spectroscopic measurements.
Antimicrobial resistance is a complex global health threat that requires a multifaceted research approach. AMR research aims to better understand the phenomena, develop effective interventions, and mitigate the global health threat posed by antimicrobial resistance. The field of AMR has seen significant advancements in recent years with researchers exploring innovative approaches to combat the growing global health threat.
Research is being done to develop antibiotic therapies, alternative approaches, improve diagnostics, infection preventions, et cetera. A variety of technologies are being employed to x-ray, research and development in the field of AMR, such as genomics and bioinformatics, nanotechnology for drug delivery and biosensors, artificial intelligence and machine learning to analyze data and patterns related to AMR. We're currently working on reducing the reaction time and optimizing the speed of the reaction under desired conditions, keeping the purity of the product our topmost priority.
Over the years, a large number of synthetic compounds have been fabricated with the potential to be utilized as antimicrobial agents. However, their synthesis involves the use of several harmful chemical solvents imparting their own potency over the test organisms, enhancing their toxicity and limiting their applications in the field of biomedical chemistry.
Overview
This study focuses on the green synthesis of a quinoline-based Ionic Liquid (IL), specifically 1-Hexadecylquinolin-1-ium bromide {[C 16 quin]Br}. The synthesis involves mixing quinoline with 1-Bromohexadecane, followed by detailed characterization using Nuclear Magnetic Resonance and Infrared spectroscopic measurements.
Key Study Components
Area of Science
- Green chemistry
- Ionic liquids
- Synthesis and characterization
Background
- Antimicrobial resistance (AMR) is a significant global health issue.
- Research in AMR focuses on understanding and developing interventions.
- Innovative approaches are being explored to combat AMR.
- Technologies like genomics and AI are utilized in AMR research.
Purpose of Study
- To elucidate the synthesis of a novel ionic liquid.
- To characterize the synthesized ionic liquid using advanced techniques.
- To contribute to the field of green chemistry.
Methods Used
- Mixing quinoline with 1-Bromohexadecane.
- Nuclear Magnetic Resonance (NMR) spectroscopy.
- Infrared (IR) spectroscopy.
- Optimization of reaction conditions for purity.
Main Results
- Successful synthesis of 1-Hexadecylquinolin-1-ium bromide.
- Characterization confirmed the structure of the ionic liquid.
- Demonstrated the potential of green synthesis methods.
- Highlighted the importance of purity in product development.
Conclusions
- The study provides insights into the synthesis of ionic liquids.
- It emphasizes the role of green chemistry in developing new materials.
- Future work may explore further applications of synthesized ILs.
Frequently Asked Questions
Executive Industry Relevance
Green synthesis of quinoline-based ionic liquids addresses the urgent need for novel antimicrobial agents amid rising antimicrobial resistance, while minimizing environmental and toxicological liabilities. This approach enables the development of bioactive compounds with improved safety profiles and supports sustainable innovation in early-stage pharmaceutical pipelines. The integration of eco-friendly synthesis and rigorous characterization enhances portfolio confidence and translational potential for next-generation antimicrobials.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Supports identification of novel antimicrobial scaffolds with reduced cytotoxicity.
- Enables functional validation of ionic liquids as bioactive agents through ADMET profiling.
- Facilitates mechanistic de-risking by confirming biological activity and artificial chaperone function.
Screening & Assay Development
- Provides chemically pure, well-characterized compounds for reliable antimicrobial screening.
- Enables reproducible disc diffusion assays to quantify antimicrobial potency.
- Supports standardization of compound evaluation through validated spectroscopic characterization.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by integrating ADMET and cytotoxicity data.
- Enables continuity from discovery to preclinical validation for antimicrobial candidates.
- Reduces risk of late-stage attrition by addressing toxicity and efficacy early in development.
Pipeline & Workflow Integration
This green synthesis method fits at the interface of early discovery and lead identification, providing high-purity, functionally validated compounds for downstream screening and preclinical evaluation.
- Discovery Biology: Enables hypothesis testing for antimicrobial activity and protein interaction modulation.
- Screening: Delivers assay-ready compounds with confirmed purity and biological potential.
- Analytics: Utilizes NMR, IR, and ADMET outputs to support quantitative comparison and decision-making.
- Translational Research: Bridges early discovery with preclinical assessment through integrated toxicity and efficacy data.
- Enterprise Reuse: Establishes a scalable, eco-friendly synthesis platform for future antimicrobial lead generation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in antimicrobial lead selection and reduces mechanistic ambiguity.
- Operational Value: Promotes standardization, reproducibility, and environmentally responsible synthesis.
- Strategic Value: Improves go/no-go decisions and capital efficiency by integrating safety and efficacy early.
- Portfolio Impact: Enables risk-adjusted prioritization of antimicrobial candidates with favorable ADMET profiles.
Implementation Considerations
- Requires expertise in green chemistry and ionic liquid synthesis.
- Needs access to NMR, IR, and biological assay infrastructure for compound validation.
- Demands cross-team alignment on purity and toxicity assessment standards.
- May require adaptation for different quinoline derivatives or target pathogens.
- Practical limitations include scalability and the need for further in vivo validation.
